"I envision a future where advances in computer intelligence and human health combine"
Will Rosellini is the CEO of Perimeter Medical, Inc and the Chairman of Nexeon Medsystems, Inc., a medical device manufacturing company that went public in 2017. He is a former pitcher with the Arizona Diamondbacks, holds a JD, MBA, MS of Accounting, MS of Computational Biology, MS of Neuroscience, and MS of Regulatory Science.
Perimeter Medical Imaging
Perimeter Medical develops, patents, and commercializes advanced in-procedural medical imaging tools.
The OTIS™ platform provides clinicians with real-time, ultra-high resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen. The ability to visualize microscopic tissue structures during the clinical procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system.
https://www.perimetermed.com
Nexeon Medsystems
A global medical device company focused on providing innovative neurostimulation products
Nexeon improves the quality of life of patients suffering from debilitating neurological disease.
https://www.nexeonmed.com
MicroTransponder
MicroTransponder Inc. (MTI) has developed the Paired Vagus Nerve Stimulation System (Paired VNS™ System) based on decades of neuroscience research. The Paired VNS™ System has been developed to treat two separate neurological conditions. The first is the Serenity® System for the treatment of chronic tinnitus. The second is the Vivistim® System for treatment of post-stroke upper limb mobility issues.
http://www.microtransponder.com
